Greece is the second and third largest patient enroller globally for two of GSK’s clinical trials in lung cancer and multiple myeloma respectively, drawing on the…
In Conversation
EU Recovery and Resilience Funding (RRF) is coming online, creating an opportunity for Greece to improve its healthcare system, which we are fully aligned with and…
The Greek healthcare system is in the initial stages of an important restructuring and reform, and there will be many opportunities going forward
It is a point of national pride to be able to assist Greek firms to enter prestigious international markets
Due to the 2008 crisis and its effects on the [Greek] pharmaceutical market, the company has given an increased focus to exports over the last few…
My team and I are constantly focused on understanding needs throughout the entire patient journey, identifying where areas for improvement exist, and how we can keep…
After almost 20 years of work, [the implementation of EU HTA legislation] will finally become a reality in 2025 with joint work on scientific consultations, clinical…
It is now once more an attractive proposition to invest in Greek manufacturing and regain some of the momentum lost in the previous decade
Our whole-of-society approach to healthcare aims to maximize health and well-being by addressing people's needs as early as possible, from health promotion and disease prevention to…
The hard times are behind us and we can look forward to a more hopeful future. We are better positioned and prepared than in the past
There is a lot to be optimistic about in Greece. For example, the implementation of a digital app and vaccination certificate during COVID-19 worked very well.…
What we are trying to do is to get new drugs that are patented into low- and middle-income countries as soon as possible – trying to…
